Article Details

Inflammatix nabs $102M in series D financing for host response diagnostics

Retrieved on: 2021-03-16 21:45:00

Tags for this article:

Click the tags to see associated articles and topics

Inflammatix nabs $102M in series D financing for host response diagnostics. View article details on hiswai:

Excerpt

D1 Capital Partners led the round, with additional funds provided by existing investors Northpond Ventures LLC, Khosla Ventures, Think.Health GmbH ...

Article found on: www.bioworld.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo